Every time through the AI Express, some investors ask questions on the investor interactive platform: 1. What is the current situation of the domestic quadrivalent influenza virus vaccine replacing the trivalent vaccine? Is it possible to use all quadrivalent vaccines in the future? Is the current domestic trivalent influenza vaccine also self-funded?
Jindick (688670.SH) said on the investor interactive platform on October 13th, hello investors, thank you for your attention and support to Jindick! 1. The quadrivalent influenza vaccine has gradually replaced the trivalent influenza vaccine since it was launched in the United States in 2013. In the 2020/21 influenza season, the proportion of the quadrivalent influenza vaccine in the US FDA influenza vaccine release batch will reach 99.8%. 2. my country’s quadrivalent influenza vaccine was first marketed in 2018. In 2020, quadrivalent influenza vaccine batches accounted for approximately 58.4% of the total influenza vaccine batches. 3. Influenza vaccine is currently a non-immunization program vaccine in China and needs to be vaccinated at one’s own expense.
(Reporter Zeng Jianhui)
Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. According to this operation, at your own risk.
1This article is the original work of “Daily Economic News”.
Without the authorization of “Daily Economic News”, it may not be used in any way, including but not limited to reprinting, extracting, copying or creating mirror images, etc., offenders must be investigated.
3Copyright cooperation telephone: 021-60900099.